期刊文献+

帕金森病细胞模型中分子伴侣介导自噬对α-突触核蛋白低聚体水平的影响

Effects of chaperone-mediated autophagy on the level of α-synuclein oligomers in Parkinson's disease cell model
下载PDF
导出
摘要 目的·探讨在泛素蛋白酶体系统(ubiquitin proteasome system,UPS)受损的帕金森病(Parkinson's disease,PD)细胞模型中分子伴侣介导自噬(chaperone-mediated autophagy,CMA)对α-突触核蛋白低聚体水平的影响。方法·培养稳转野生型α-突触核蛋白的人神经母细胞瘤SK-N-SH细胞系,加入蛋白酶体抑制剂lactacystin构建PD细胞模型。通过Western blotting检测α-突触核蛋白低聚体、溶酶体相关膜蛋白2A型(lysosome-associated membrane protein type 2A,LAMP2A)和相对分子质量为70 000的热休克同源蛋白(heat-shock cognate protein of 70 kDa,HSC70)水平;使用LAMP2A siRNA抑制CMA功能,检测对α-突触核蛋白低聚体水平及细胞存活率的影响;通过免疫共沉淀观察LAMP2A与α-突触核蛋白低聚体的相互作用。结果·PD细胞模型中α-突触核蛋白低聚体表达水平升高,与CMA功能密切相关的蛋白LAMP2A和HSC70水平应激性增加;抑制LAMP2A表达,α-突触核蛋白低聚体水平进一步升高,细胞存活率降低,且通过免疫共沉淀检测到LAMP2A与α-突触核蛋白低聚体存在相互作用。结论·PD细胞模型中,CMA是调节α-突触核蛋白低聚体水平的途径之一,抑制其功能可进一步增加α-突触核蛋白低聚体水平及细胞毒性作用。 Objective · To investigate the effects of chaperone-mediated autophagy (CMA) on α-synuclein oligomers level in the Parkinson's disease (PD) cell model with impaired ubiquitin proteasome system (UPS). Methods · The PD cell model was established by adding the proteasome inhibitor lactacystin in the SK-N-SH cell line stably transfected with wild type α-synuclein. The levels of α-synuclein oligomers, lysosome-associated membrane protein type 2A (LAMP2A) and 70 kDa heat shock homologous protein (HSC70) were detected using Western blotting. CMA function was inhibited with LAMP2A siRNA, and its effects on α-synuclein oligomers and cell viability were detected. Furthermore, the interaction of LAMP2A with α-synuclein oligomers was detected by immunoprecipitation. Results · In the PD cell model, the levels of α-synuclein oligomers, and CMA related proteins, i.e. LAMP2A and HSC70, were increased. Inhibiting the expression of LAMP2A further increased α-synuclein oligomers level, while it decreased cell viability. Furthermore, LAMP2A could interact with α-synuclein oligomers. Conclusion · In the PD cell model, CMA is one of the pathways regulating α-synuclein oligomers level. Inhibiting CMA function can further increase the α-synuclein oligomers level and deteriorate cell survival.
作者 杨笑 杜芸兰 白雪峰 朱德生 王飞 韩露 管阳太 YANG Xiao;DU Yun-lan;BAI Xue-feng;ZHU De-sheng;WANG Fei;HAN Lu;GUAN Yang-tai(Department of Neurology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China;Pediatric Translational Medicine Institute,Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China)
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2019年第3期239-243,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(81671247) 上海市自然科学基金(16ZR1420100)~~
关键词 帕金森病 α- 突触核蛋白 低聚体 分子伴侣介导自噬 Parkinson's disease (PD) α-synuclein oligomers chaperone-mediated autophagy (CMA)
  • 相关文献

参考文献1

二级参考文献14

  • 1Carew JS, Giles FJ, Nawrocki ST. Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy [J]. CancerLett, 2008, 269(1): 7-17.
  • 2Chen PS, Wang CC, Bortner CD, et al. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity[J]. Neuroscience, 2007, 149(1) : 203 -212.
  • 3Su M, Shi JJ, Yang YP, et al. HDAC6 regulates aggresome-autophagy degradation pathway of cL-synuclein in response to MPP -induced stress[J]. JNeurochem, 2011, 117(1): 112-120.
  • 4Du G, Liu X, Chen X, et al. Drosophila histone deaeetylase 6 protects dopaminergic neurons against c-synuelein toxicity by promoting inclusion formation[ Jl. Mol Biol Cell, 2010, 21 ( 13 ) : 2128 -2137.
  • 5Ding H, Dolan PJ, Johnson GV. Histonc deaeetylase 6 interacts with the microtubule-associated protein tau[J]. J Neurochem, 2008, 106(5) : 2119 -2130.
  • 6Kawaguchi Y, Kovacs JJ, McLaurin A, et al. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress [ J ]. Cell, 2003, 115 (6) : 727 -738.
  • 7Du Y, Wang F, Zou J, et al. Histone deacetylase 6 regulates cytotoxic c-synuclein accumulation through induction of the heat shock response [ J]. Neurobiol Aging, 2014, 35 (10) : 2316 - 2328.
  • 8Simes-Pires C, Zwick V, Nurisso A, et al. HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs? [J] Mol Neurodegener, 2013, 8(5): 7.
  • 9Simms-Waldrip T, Rodriguez-Gonzalez A, Lin T, et al. The aggre- some pathway as a target for therapy in hematologic malignancies [J]. Mol Genet Metab, 2008, 94(3): 283 -286.
  • 10Miki Y, Mori F, Tanji K, et al. Accumulation of histone deacetylase 6, an aggresome-related protein, is specific to Lewy bodies and glial cytoplasmic inclusions [ J ]. Neuropathology, 2011, 31 (6) : 561 - 568.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部